|
Volumn 42, Issue 8, 2010, Pages 3038-3040
|
Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: A single-center, randomized study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DOSAGE SCHEDULE COMPARISON;
DOSE TIME EFFECT RELATION;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG FORMULATION;
FEMALE;
GLOMERULUS FILTRATION RATE;
GRAFT SURVIVAL;
HUMAN;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
OPEN STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STATISTICAL SIGNIFICANCE;
AGED;
ANTIBODIES, MONOCLONAL;
AREA UNDER CURVE;
DELAYED-ACTION PREPARATIONS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
PREDNISONE;
RECOMBINANT FUSION PROTEINS;
TACROLIMUS;
TISSUE DONORS;
|
EID: 77958527015
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.08.008 Document Type: Article |
Times cited : (13)
|
References (7)
|